Ncardia
Biotechnology Research • 
Leiden, South Holland, Netherlands • 21-50 Employees
Company overview
| Headquarters | Ncardia Leiden, Galileiweg 8, Building BioPartner 1, Leiden, South Holland 2333 BD , NL |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | Stem Cells, CRO, Drug Discovery, CMO, Drug Development, Toxicology, Electrophysiology, Disease Modeling, HTS, Assay Development, Safety Pharmacology, Cardiomyocytes, Ipsc, Neurons, Fibroblast, Assay Solutions, Astrocytes, Cardiovascular Efficacy, Cardiovascular Safety, Contraction Assays, Custom Cell Lines, Neural Efficacy, Neural Safety |
| Founded | 2011 |
| Employees | 21-50 |
| Socials |
Key Contacts at Ncardia
John Lamb
Director Of Innovation & Business Development - Stem Cells For Drug Discovery
Charles Leach
Director Of Business Development | Europe & Row
Timothy Smith
Senior Director Of Business Development - West Coast
Mariana Argenziano
Associate Director Manufacturing Technology
Shushant Jain
Director Discovery
Silke Schwengberg
Associate Director Cardiac Disease
Toni Krainz
Director Of Business Development - Europe
Peter Udall
Senior Director, Business Development - Western Us
Sanne Holt
Associate Director Immuno-Oncology
Ncardia Email Formats
Ncardia uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@ncardia.com), used 60.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@ncardia.com | 60.6% |
{first initial}.{last name} | j.doe@ncardia.com | 36.4% |
{first initial} | j@ncardia.com | 3% |
About Ncardia
Ncardia is a drug discovery company and expert in human iPSC technology. We operate worldwide with facilities, offices and staff throughout Europe and North America. We work with biopharmaceutical companies in drug discovery worldwide, to leverage the power of stem cell technologies in the development of novel therapies of multiple modalities at any stage of development. Over the past 10 years, we have built the expertise and infrastructure required to differentiate, manufacture and characterize high-quality iPSC-derived cell and disease models. We can facilitate the process of disease modeling and high-throughput screening to accelerate drug discovery. We listen to our customer’s project plans, questions and challenges, and co-develop human iPSC-based solutions that fit their specifications. Explore our website to learn more www.ncardia.com.
Ncardia revenue & valuation
| Annual revenue | $2,000,000 |
| Revenue per employee | $41,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $6,400,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Ncardia has 16 employees across 7 departments.
Departments
Number of employees
Funding Data
Ncardia has never raised funding before.
Ncardia Tech Stack
Discover the technologies and tools that power Ncardia's digital infrastructure, from frameworks to analytics platforms.
CDN
Font scripts
Security
Cookie compliance
JavaScript libraries
Tag managers
CMS
Miscellaneous
Security
Miscellaneous
JavaScript libraries
JavaScript libraries
New Zealand
France
Frequently asked questions
4.8
40,000 users
